Skip to main content

Table 3 Quality assessment of vaccine trials for immunization against – ETEC

From: Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus

Results for ETEC

Outcomes

No of Studies

No of Participants

Impact Estimates (95% CI)

Serum Ig A seroconversion

2 [42, 47]

157

2.70 [1.87, 3.90]a

Serum Ig G seroconversion

2 [42, 47]

157

4.99 [2.51, 9.92]a

Adverse Events

4 [43, 44, 46, 47]

1169

1.58 (1.14, 2.19)a

  1. a: Fixed Effect Model
  2. b: Random Effect Model
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us